Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A

Molecular and Cellular Biology

Volumn 28, Issue 19, 2008, Pages 5899-5911

  Aranda, Sergi ^a   Alvarez, Mónica ^a,d   Turró, Silvia ^a   Laguna, Ariadna ^a   De La Luna, Susana ^a,b,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; PROTEIN KINASE DYRK1A; RAF PROTEIN; SPROUTY PROTEIN; SPROUTY2 PROTEIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CELL STRAIN HEK293; EMBRYO; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BRAIN; CELL LINE; FIBROBLAST GROWTH FACTORS; HUMANS; MEMBRANE PROTEINS; MICE; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 52649114829     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00394-08     Document Type: Article

References (49)

1. Alvarez, M., X. Altafaj, S. Aranda, and S. de la Luna. 2007. DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding. Mol. Biol. Cell 18:1167-1178.
2. Alvarez, M., X. Estivill, and S. de la Luna. 2003. DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. J. Cell Sci. 116:3099-3107.
3. Arron, J. R., M. M. Winslow, A. Polleri, C. P. Chang, H. Wu, X. Gao, J. R. Neilson, L. Chen, J. J. Heit, S. K. Kim, N. Yamasaki, T. Miyakawa, U. Francke, I. A. Graef, and G. R. Crabtree. 2006. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600.
4. Basson, M. A., D. Echevarria, C. P. Ahn, A. Sudarov, A. L. Joyner, I. J. Mason, S. Martinez, and G. R. Martin. 2008. Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signaling during development. Development 135:889-898.
5. Benavides-Piccione, R., M. Dierssen, I. Ballesteros-Yanez, M. Martinez de Lagran, M. L. Arbones, V. Fotaki, J. DeFelipe, and G. N. Elston. 2005. Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse. Neurobiol. Dis. 20:115-122.
6. Branchi, I., Z. Bichler, L. Minghetti, J. M. Delabar, F. Malchiodi-Albedi, M. C. Gonzalez, Z. Chettouh, A. Nicolini, C. Chabert, D. J. Smith, E. M. Rubin, D. Migliore-Samour, and E. Alleva. 2004. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. J. Neuropathol. Exp. Neurol. 63:429-440.
7. Cabrita, M. A., F. Jaggi, S. P. Widjaja, and G. Christofori. 2006. A functional interaction between Sprouty proteins and caveolin-1. J. Biol. Chem. 281:29201-29212.
8. Casci, T., J. Vinos, and M. Freeman. 1999. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96:655-665.
9. Chandramouli, S., C. Y. Yu, P. Yusoff, D. H. Lao, H. F. Leong, K. Mizuno, and G. R. Guy. 2008. Tcsk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling. J. Biol. Chem. 283:1679-1691.
10. DaSilva, J., L. Xu, H. J. Kim, W. T. Miller, and D. Bar-Sagi. 2006. Regulation of Sprouty stability by Mnk1-dependent phosphorylation. Mol. Cell. Biol. 26:1898-1907.
11. de la Luna, S., K. E. Allen, S. L. Mason, and N. B. La Thangue. 1999. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J. 18:212-228.
12. de la Luna, S., and X. Estivill. 2006. Cooperation to amplify gene-dosage-imbalance effects. Trends Mol. Med. 12:451-454.
13. Dierssen, M., and M. M. de Lagran. 2006. DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis. ScientificWorldJournal 6:1911-1922.
14. Ebisuya, M., K. Kondoh, and E. Nishida. 2005. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell Sci. 118:2997-3002.
15. Epstein, C. J. 2006. Down's syndrome: critical genes in a critical region. Nature 441:582-583.
16. Fong, C. W., H. F. Leong, E. S. Wong, J. Lim, P. Yusoff, and G. R. Guy. 2003. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J. Biol. Chem. 278:33456- 33464.
17. Fotaki, V., M. Dierssen, S. Alcantara, S. Martinez, E. Marti, C. Casas, J. Visa, E. Soriano, X. Estivill, and M. L. Arbones. 2002. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol. Cell. Biol. 22:6636-6647.
18. Gross, I., O. Armant, S. Benosman, J. L. de Aguilar, J. N. Freund, M. Kedinger, J. D. Licht, C. Gaiddon, and J. P. Loeffler. 2007. Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ. 14:1802-1812.
19. Gross, I., B. Bassit, M. Benezra, and J. D. Licht. 2001. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J. Biol. Chem. 276:46460-46468.
20. Hacohen, N., S. Kramer, D. Sutherland, Y. Hiromi, and M. A. Krasnow. 1998. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92:253-263.
21. Hall, A. B., N. Jura, J. DaSilva, Y. J. Jang, D. Gong, and D. Bar-Sagi. 2003. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr. Biol. 13:308-314.
22. Hanafusa, H., S. Torii, T. Yasunaga, and E. Nishida. 2002. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4:850-858.
23. Himpel, S., W. Tegge, R. Frank, S. Leder, H. G. Joost, and W. Becker. 2000. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J. Biol. Chem. 275:2431-2438.
24. Hoque, M., T. M. Young, C. G. Lee, G. Serrero, M. B. Mathews, and T. Pe'ery. 2003. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Mol. Cell. Biol. 23:1688-1702.
25. 2+ ion links the cytoplasmic tail of CD4 and the N-terminal region of Lck. J. Biol. Chem. 273:18729-18733.
26. Huttner, W. B., W. Schiebler, P. Greengard, and P. De Camilli. 1983. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J. Cell Biol. 96:1374-1388.
27. Ibanez, C. F. 2007. Message: in a bottle: long-range retrograde signaling in the nervous system. Trends Cell Biol. 17:519-528.
28. Impagnatiello, M. A., S. Weitzer, G. Gannon, A. Compagni, M. Cotten, and G. Christofori. 2001. Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J. Cell Biol. 152:1087-1098.
29. Kelly, P. A., and Z. Rahmani. 2005. DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1. Mol. Biol. Cell 16:3562-3573.
30. Kim, H. J., L. J. Taylor, and D. Bar-Sagi. 2007. Spatial regulation of EGFR signaling by Sprouty2. Curr. Biol. 17:455-461.
31. Kortenjann, M., O. Thomae, and P. E. Shaw. 1994. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol. Cell. Biol. 14:4815-4824.
32. Lao, D. H., P. Yusoff, S. Chandramouli, R. J. Philp, C. W. Fong, R. A. Jackson, T. Y. Saw, C. Y. Yu, and G. R. Guy. 2007. Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation. J. Biol. Chem. 282:9117-9126.
33. Lim, J., E. S. Wong, S. H. Ong, P. Yusoff, B. C. Low, and G. R. Guy. 2000. Sprouty proteins are targeted to membrane ruffles upon growth factor receptor tyrosine kinase activation. Identification of a novel translocation domain. J. Biol. Chem. 275:32837-32845.
34. Liu, A., J. Y. H. Li, C. Bromleigh, Z. Lao, L. A. Niswander, and A. L. Joyner. 2003. FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or activated FGF receptors. Development 130:6175-6185.
35. Marti, E., X. Altafaj, M. Dierssen, S. de la Luna, V. Fotaki, M. Alvarez, M. Perez-Riba, I. Ferrer, and X. Estivill. 2003. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res. 964:250-263.
36. Mason, J. M., D. J. Morrison, B. Bassit, M. Dimri, H. Band, J. D. Licht, and I. Gross. 2004. Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop. Mol. Biol. Cell 15:2176-2188.
37. Mason, J. M., D. J. Morrison, M. A. Basson, and J. D. Licht. 2006. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16:45-54.
38. Minowada, G., L. A. Jarvis, C. L. Chi, A. Neubuser, X. Sun, N. Hacohen, M. A. Krasnow, and G. R. Martin. 1999. Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development 126:4465-4475.
39. Murakami, N., W. Xie, R. C. Lu, M. C. Chen-Hwang, A. Wieraszko, and Y. W. Hwang. 2006. Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome. J. Biol. Chem. 281:23712-23724.
40. Ozaki, K., S. Miyazaki, S. Tanimura, and M. Kohno. 2005. Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms. J. Cell Sci. 118:5861-5871.
41. Pawson, T., and P. Nash. 2000. Protein-protein interactions define specificity in signal transduction. Genes Dev. 14:1027-1047.
42. Rubin, C., V. Litvak, H. Medvedovsky, Y. Zwang, S. Lev, and Y. Yarden. 2003. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr. Biol. 13:297-307.
43. Sasaki, A., T. Taketomi, R. Kato, K. Saeki, A. Nonami, M. Sasaki, M. Kuriyama, N. Saito, M. Shibuya, and A. Yoshimura. 2003. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat. Cell Biol. 5:427-432.
44. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-225.
45. Schubbert, S., K. Shannon, and G. Bollag. 2007. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7:295-308.
46. Tefft, J. D., M. Lee, S. Smith, M. Leinwand, J. Zhao, P. Bringas, Jr., D. L. Crowe, and D. Warburton. 1999. Conserved function of mSpry-2, a murine homolog of Drosophila sprouty, which negatively modulates respiratory organogenesis. Curr. Biol. 9:219-222.
47. Tsavachidou, D., M. L. Coleman, G. Athanasiadis, S. Li, J. D. Licht, M. F. Olson, and B. L. Weber. 2004. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. Cancer Res. 64:5556-5559.
48. Ubersax, J. A., and J. E. Ferrell, Jr. 2007. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8:530-541.
49. Yusoff, P., D. H. Lao, S. H. Ong, E. S. Wong, J. Lim, T. L. Lo, H. F. Leong, C. W. Fong, and G. R. Guy. 2002. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J. Biol. Chem. 277:3195-3201.